Action

VEGFRs

Alt Name

Approval Jurisdiction

2018 China

Approved for clinical use

NSCLC

Brutto

CAS

1058156-90-3

Commercial Vendor

Advenchen Laboratories

Compound Image

Catequentinib.png

Compound name

Catequentinib

InChI

InChI=1S/C23H22FN3O3/c1-13-9-15-16(27-13)3-4-19(22(15)24)30-18-5-8-26-17-11-21(20(28-2)10-14(17)18)29-12-23(25)6-7-23/h3-5,8-11,27H,6-7,12,25H2,1-2H3

InChI Key

KSMZEXLVHXZPEF-UHFFFAOYSA-N

MW

407.40

PubChem CID

25017411

Reference

Reference 2

SMILES

CC1=CC2=C(N1)C=CC(=C2F)OC3=C4C=C(C(=CC4=NC=C3)OCC5(CC5)N)OC

Approved Drug List

1